Clotting factor activity levels and bleeding risk in people with haemophilia playing sports.
haemophilia
joint bleeds
sports
sports injuries
sports-induced bleeds
Journal
Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
revised:
24
04
2023
received:
14
10
2022
accepted:
07
05
2023
medline:
21
7
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
ppublish
Résumé
Improved treatment options for people with haemophilia (PWH) have increased the possibilities for sports participation, but the risk of sports-induced bleeding (SIB) is still considered considerable by many. To assess sports associated injury- and bleeding risk in PWH and to assess clotting levels associated with safe sports participation. Sports injuries and SIBs were prospectively collected for 12 months in PWH aged 6-49 without inhibitors playing sports at least once weekly. Injuries were compared according to factor levels, severity, joint health, sports risk category and sports intensity. Factor activity at the time of injury was estimated using a pharmacokinetic model. 125 participants aged 6-49 (41 children, 90% haemophilia A; 48% severe, 95% severe on prophylaxis) were included. Sports injuries were reported by 51 participants (41%). Most participants (62%) reported no bleeds at all and only 16% reported SIBs. SIBs were associated with factor levels at time of injury (OR: 0.93/%factor level (CI 0.88-0.99); p = .02), but not with haemophilia severity (OR: 0.62 (CI 0.20-1.89); p = .40), joint health, sports risk category or sports intensity. PWH with factor levels <10% during sports injury had a bleeding risk of 41% versus 20% in those with higher (>10%) factor levels. The results of this study emphasize the importance of clotting factor levels in prevention of bleeds. This information is vital for patient counselling and tailoring prophylactic treatment with clotting factors and non-replacement therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Improved treatment options for people with haemophilia (PWH) have increased the possibilities for sports participation, but the risk of sports-induced bleeding (SIB) is still considered considerable by many.
AIM
OBJECTIVE
To assess sports associated injury- and bleeding risk in PWH and to assess clotting levels associated with safe sports participation.
METHODS
METHODS
Sports injuries and SIBs were prospectively collected for 12 months in PWH aged 6-49 without inhibitors playing sports at least once weekly. Injuries were compared according to factor levels, severity, joint health, sports risk category and sports intensity. Factor activity at the time of injury was estimated using a pharmacokinetic model.
RESULTS
RESULTS
125 participants aged 6-49 (41 children, 90% haemophilia A; 48% severe, 95% severe on prophylaxis) were included. Sports injuries were reported by 51 participants (41%). Most participants (62%) reported no bleeds at all and only 16% reported SIBs. SIBs were associated with factor levels at time of injury (OR: 0.93/%factor level (CI 0.88-0.99); p = .02), but not with haemophilia severity (OR: 0.62 (CI 0.20-1.89); p = .40), joint health, sports risk category or sports intensity. PWH with factor levels <10% during sports injury had a bleeding risk of 41% versus 20% in those with higher (>10%) factor levels.
CONCLUSION
CONCLUSIONS
The results of this study emphasize the importance of clotting factor levels in prevention of bleeds. This information is vital for patient counselling and tailoring prophylactic treatment with clotting factors and non-replacement therapy.
Substances chimiques
Blood Coagulation Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1013-1023Subventions
Organisme : Bayer
ID : BHC-RD-SOP-038
Informations de copyright
© 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd.
Références
Pulles AE, Mastbergen SC, Schutgens REG, Lafeber FPJG, van Vulpen LFD. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017;115:192-199. doi:10.1016/j.phrs.2016.11.032
World Health Organization. WHO Guidelines on Physical Activity and Sedentary Behaviour. 2020.
Ross C, Goldenberg NA, Hund D, MJ Manco-Johnson. Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis. Pediatrics. 2009;124(5):1267-1272. doi:10.1542/peds.2009-0072
Schoenmakers MAGC, Gulmans VAM, Helders PJM, van den Bergj HM. Motor performance and disability in dutch children with haemophilia: a comparison with their healthy peers. Haemophilia. 2001;7(3):293-298.
Srivastava A, Santagostino E, Dougall A, Al E. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(S6):1-158. doi:10.1111/hae.14046 3rd edition
Anderson A, Forsyth A. Playing it safe: bleeding disorders, sports and exercise. National Hemophilia Foundation. 2017. doi:10.1136/jech.2007.061960
Groen WG, Takken T, van der Net J, Helders PJM, Fischer K. Habitual physical activity in Dutch children and adolescents with haemophilia. Haemophilia. 2011;17(5):906-912. doi:10.1111/j.1365-2516.2011.02555.x
Versloot O, van Balen EC, Hassan S, et al. Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study. Haemophilia. 2021;27:876-855. doi:10.1111/hae.14366
Versloot O, Timmer MA, de Kleijn P, et al. Sports participation and sports injuries in Dutch boys with haemophilia. Scand J Med Sci Sports. 2020;30(7):1256-1264. doi:10.1111/sms.13666
van Mechelen W, Hlobil H, Kemper HCG. Incidence, severity, aetiology and prevention of sports injuries: a review of concepts. Sports Med. 1992;14(2):82-99. doi:10.2165/00007256-199214020-00002
Emery CA. Risk factors for injury in child and adolescent sport: a systematic review of the literature. Clin J Sport Med. 2003;13(4):256-268. doi:10.1136/bjsports-2014-094372
McGee S, Raffini L, Witmer CM. Organized sports participation and the association with injury in paediatric patients with haemophilia. Haemophilia. 2015;21(4):538-542. doi:10.1111/hae.12696
Ross C, Goldenberg N, Hund D, MJ Manco-Johnson. Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis. Pediatrics. 2009;124(5):1267-1272. doi:10.1542/peds.2009-0072
Organizatio World. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053
European Committee. The European Sports Charter. 1992.
Aaron DJ, Kriska AM, Dearwater SR, et al. The epidemiology of leisure physical activity in an adolescent population. Med Sci Sports Exerc. 1993;25(7):847-853.
Kriska AM, Knowler WC, LaPorte RE, et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care. 1990;13(4):401-411. doi:10.2337/diacare.13.4.401
Tonoli C, Heyman E, Roelands B, Georges B, Berthoin S, Meeusen R. Validation and reliability of the Dutch language version of the modifiable activity questionnaire in healthy subjects. Sport Sci Health. 2013;9(3):139-144. doi:10.1007/s11332-013-0160-y
Bussmann. Validation of the Active8 Activity Monitor : Detection of Body Postures and Movements. Erasmus MC University Medical Center Rotterdam. 2013;18.
Fanchamps MHJ, Horemans HLD, Ribbers GM, Stam HJ, Bussmann JBJ. The accuracy of the detection of body postures and movements using a physical activity monitor in people after a stroke. Sensors (Switzerland). 2018;18(7):2167-2177. doi:10.3390/s18072167
Valkenet K, Veenhof C. Validity of three accelerometers to investigate lying, sitting, standing and walking. PLoS One. 2019;14(5):1-9. doi:10.1371/journal.pone.0217545
Timmer MA, Veenhof C, de Kleijn P, de Bie RA, Schutgens REG, Pisters MF. Movement behaviour patterns in adults with haemophilia. Ther Adv Hematol. 2020;11:1-9. doi:10.1177/2040620719896959
Fischer K, de Kleijn P. Using the haemophilia joint health score for assessment of teenagers and young adults: exploring reliability and validity. Haemophilia. 2013;19(6):944-950. doi:10.1111/hae.12197
Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the international hemophilia prophylaxis study group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011;63(2):223-230. doi:10.1002/acr.20353
Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res. 1980(149):153-159.
Sluiter D, Foppen W, de Kleijn P, Fischer K. Haemophilia joint health score in healthy adults playing sports. Haemophilia. 2014;20(2):282-286. doi:10.1111/hae.12290
Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575-1581. doi:10.1249/MSS.0b013e31821ece12
van Vulpen AV. Sport for All: Sports Injuries and Their Prevention. Council of Europe, Nationaal instituut voor Sportgezondheidszorg; 1989.
Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-1939. doi:10.1111/jth.12672
Hajducek DM, Chelle P, Hermans C, et al. Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project. Haemophilia. 2020;26(3):384-400. doi:10.1111/hae.13977
McEneny-King A, Chelle P, Foster G, Keepanasseril A, Iorio A, Edginton AN. Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization. J Pharmacokinet Pharmacodyn. 2019;46(5):411-426. doi:10.1007/s10928-019-09634-7
National Institute for Public Health and the Environment (RIVM), Dutch Consumer Safety Institute (VeiligheidNL) in collaboration with Statistics Netherlands. Additional Module Physical Activity and Accidents/Lifestyle Monitor. 2019.
Stam C, Valkenberg H. Sportblessures in Nederland - Cijfers 2019. 2020.
Phillips L. Sports injury incidence. Br J Sports Med. 2000;34:133-136. doi:10.1136/bjsm.34.2.133
Versloot O, van der Net J, Fischer K. Sports participation of patients with haemophilia in the COVID-19 era: the Dutch experience. Haemophilia. 2021;27(2):e295-e297. doi:10.1111/hae.14189
RStudio Team. RStudio: Integrated Development for R. Published online 2020.
Ceponis A, Wong-Sefidan I, Glass CSS, von Drygalski A. Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients. Haemophilia. 2013;19(5):790-798. doi:10.1111/hae.12175
Broderick CR, Herbert RD, Latimer J, et al. Association between physical activity and risk of bleeding in children with hemophilia. JAMA. 2012;308(14):1452-1459. doi:10.1001/jama.2012.12727.eTable
Den Uijl IEM, Fischer K, Van Der Bom JG, Grobbee DE, Rosendaal FR, Plug I. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels. Haemophilia. 2011;17(1):41-44. doi:10.1111/j.1365-2516.2010.02383.x
Bukkems L, Versloot O, Cnossen M, et al. Association between sports participation, factor VIII levels and bleeding in hemophilia A. Thromb Haemost. 2022. doi:10.1055/a-1983-0594
Kizilocak H, Marquez-Casas E, Malvar J, Carmona R, Young G. Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays. Haemophilia. 2021;27(5):730-735. doi:10.1111/hae.14359
Guo Z, Gill TMM, Allore HGHG. Modeling repeated time-to-event health conditions with discontinuous risk intervals: an example of a longitudinal study of functional disability among older persons. Methods Inf Med. 2008;47(2):107-116. doi:10.3414/ME0478